Management of COVID-19 Severe Illness

Clinical Signs and Symptoms

Management Approaches

  • A patient having severe pneumonia, acute respiratory distress syndrome (ARDS), sepsis or patients responding to noninvasive management.
  • These patients manifest with:
    • Dyspnea, RR ≥ 30/min
    • Blood oxygen saturation(SpO2) ≤ 90%,
    • Or Arterial Blood Gas (ABG) PaO2/FiO2 ratio < 300 OR when Kigali definition is used SpO2/FIO2 <350,
    • and/or lung infiltrates in CT imaging > 50% within 24 to 48 hours;
  • CURB-65 score using confusion, Urea>7mmol/L or abnormal creatinine value, respiratory rate >30, Blood pressure <90/60, Age >65 can be used to determine severity of pneumonia.
  • CURB-65 score > 2 indicates severe pneumonia
  • Provide oxygen supplementation for SpO2 target ≥ 92-96% (for pregnant mother, patients with hemodynamic instability SpO2 target >92-94%)
  • Empiric antimicrobials should be started after taking specimen for culture and sensitivity
  • For patients who are severely ill and critical, hospitalized, immunocompromised or with previous structural lung disorder start an antibiotic.
  • Ceftazidime / Cefepime 2g IV TID +/- Vancomycin 1 gm IV BID
  • Ceftriaxone 1gm IV bid is an alternative to ceftazidime / Cefepime but not routinely used because of the high rate of resistance.
  • If there is no response with the above antibiotics or culture and sensitivity result suggests it Meropenem (or other available carbapenems) 1g IV q 8hours +/- Vancomycin 1g IV q12 hours can be used.
  • When patients improve and can take PO switch to Amoxicillin- clavulanate  as in the management of moderate cases.